Records containing: Ovarian Neoplasms

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-07-15
Cohort C: Open-label Phase 2, Randomized, Controlled Multicenter Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer
CLINICAL_TRIALS study record update · 2025-06-26
An Indian Multicentric, Open Label, Prospective Phase 4 Study of Bevacizumab in the Front Line Management of Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer in Real-life Clinical Practice
CLINICAL_TRIALS study record update · 2025-06-25
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
CLINICAL_TRIALS study record update · 2025-06-18
DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
CLINICAL_TRIALS study record update · 2025-06-18
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-06-15
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV07/ ENGOT-ov80 Study)
CLINICAL_TRIALS study record update · 2025-05-23
Ultrasound-guided Transvaginal Aspiration of Cystic Pelvic Lesions
CLINICAL_TRIALS study record update · 2025-05-18
Identification of Ovarian Malignancy With Ultrasonography Based Criteria (IOTA) and Serum CA 125
CLINICAL_TRIALS study record update · 2025-05-06
A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMIC, AND ANTITUMOR ACTIVITY OF PF-07260437 IN ADVANCED OR METASTATIC SOLID TUMORS
CLINICAL_TRIALS study record update · 2025-04-06
Diagnosing Ovarian Cysts - the DOC Study
CLINICAL_TRIALS study record update · 2025-03-26
Efficiency of Laparoscopic Interval Cytoreductive Surgery After Neoadjuvant Chemotherapy in Patients With Stage III and IV Epithelial Ovarian Cancer
CLINICAL_TRIALS study record update · 2025-03-21
A Prospective, Multicentre, Open Labelled, Single Arm Phase-IV Clinical Trial of Niraparib in Indian Patients With Advanced or Relapsed Ovarian Cancer Who Are in Complete or Partial Response Following Platinum Based Chemotherapy
CLINICAL_TRIALS study record update · 2025-03-07
Phase II Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
CLINICAL_TRIALS study record update · 2025-02-28
Phase II Study of AK112 (Anti-PD-1 and VEGF Bi-specific Antibody) in the Treatment of Advanced Gynecological Carcinoma
CLINICAL_TRIALS study record update · 2025-02-11
Phase I/II Clinical Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Preliminary Efficacy of VB15010 Tablets In Patients With Advanced Solid Tumors
CLINICAL_TRIALS study record update · 2025-02-10
A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors
CLINICAL_TRIALS study record update · 2025-02-07
A Phase 1 Study of SGN-STNV in Advanced Solid Tumors
CLINICAL_TRIALS study record update · 2025-02-04
Validation of Ovarian Adnexal Mass Assessment Score Test System
CLINICAL_TRIALS study record update · 2025-01-20
Cancer Loyalty Card Study: a Retrospective Observational Case-Control Study
CLINICAL_TRIALS study record update · 2025-01-16
ClinicalTrials.gov study NCT02811224
CLINICAL_TRIALS study record update · 2025-01-10
Italian Multicenter Randomized Phase II Study of Weekly Paclitaxel vs. Cediranib-Olaparib (Continuous vs. Intermittent) in Patients With Platinum Resistant High Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
CLINICAL_TRIALS study record update · 2024-12-30
Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations Independent of HER2 Expression With Progression After Previous Treatment
CLINICAL_TRIALS study record update · 2024-12-18
A Phase 1, First in Human Study of Adenovirally Transduced Autologous Macrophages Engineered to Contain an Anti-HER2 Chimeric Antigen Receptor in Subjects With HER2 Overexpressing Solid Tumors
CLINICAL_TRIALS study record update · 2024-12-11
Post-Marketing Surveillance (Usage Results Study) of Niraparib in the Treatment of Adult Patients for Approved Indications in South Korea
CLINICAL_TRIALS study record update · 2024-10-31
A Phase Ⅰ/Ⅱ Study of TTI-622 in Combination With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer